Non-invasive evaluation of coronary reserve - Assessment of coronary reserve in patients with coronary artery disease by transesophageal-Doppler echocardiography
Ai. Kranidis et al., Non-invasive evaluation of coronary reserve - Assessment of coronary reserve in patients with coronary artery disease by transesophageal-Doppler echocardiography, INT J CARD, 68(1), 1999, pp. 107-113
Citations number
33
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
We assessed coronary flow reserve using transesophageal Doppler echocardiog
raphy in patients with coronary artery disease. The study included 33 coron
ary artery disease patients who were undergoing coronary arteriography. The
blood flow velocities of the left anterior descending artery before and af
ter intravenous infusion (0.56 mg/min for 4 min) of dipyridamole were recor
ded using transesophageal Doppler echocardiography. Fourteen normal healthy
individuals, matched forage, served as a control group. The index of coron
ary flow reserve, i.e. the ratio of dipyridamole to baseline maximum diasto
lic velocity, was calculated. Maximal coronary flow reserve in coronary art
ery disease patients was significantly lower than in the control group (1.4
+/-0.2 vs. 2.8+/-0.3, P<0.001). The coronary artery disease patients were c
lassified into three groups: Group A included 10 patients with <50% left an
terior descending artery stenosis; Group B included seven patients with 50-
69% left anterior descending artery stenosis; 16 patients with >70% left an
terior descending artery stenosis constituted Group C. The maximum coronary
flow reserve was significantly different for A vs. B and A vs. C. (A, 1.77
+/-0.18; B, 1.51+/-0.1; C, 1.28+/-0.24). A strong and significant correlati
on was found between the maximum coronary flow reserve and the degree of pr
oximal left anterior descending artery stenosis (r=0.78, P<0.001). Coronary
artery disease patients without left anterior descending artery stenosis o
n the arteriogram exhibited lower maximum coronary flow reserve compared to
the control subjects (1.78+/-0.19 vs. 2.8+/-0.3, P=0.000). (C) 1999 Elsevi
er Science Ireland Ltd. All rights reserved.